Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 8,440,183 | Angiogenin complexes (ANGex) with lipid-based substrates and uses thereof | Jul 18, 11 | May 14, 13 | NAIDU LP |
| 8,440,204 | neurotoxin type A and uses thereof | Apr 29, 10 | May 14, 13 | WISCONSIN ALUMNI RESEARCH FOUNDATION; THE SCRIPPS RESEARCH INSTITUTE; |
| 8,440,210 | Stabilized pharmaceutical product | Apr 02, 12 | May 14, 13 | TAKEDA GMBH |
| 8,440,228 | Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease | Apr 04, 05 | May 14, 13 | KUREHA CORPORATION |
| 8,440,232 | Methods of treatment using a gastric retained gabapentin dosage | Oct 10, 11 | May 14, 13 | DEPOMED, INC. |
| 8,440,615 | Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase | Apr 23, 08 | May 14, 13 | SOCIETE D'EXTRACTION DES PRINCIPES ACTIFS (VINCIENCE) |
| 8,440,617 | Hyperbaric treatment in wound healing | Mar 21, 08 | May 14, 13 | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 8,440,618 | Composition for the attachment of implants to collagen or other components of biological tissue | Jan 19, 12 | May 14, 13 | NEW YORK SOCIETY FOR THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY; THE TRUSTEES OF PRINCETON UNIVERSITY; THE TEXAS A&M UNIVERSITY SYSTEM; |
| 8,440,621 | Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels | Nov 01, 11 | May 14, 13 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; BACHEM BIOSCIENCES, INC.; |
| 8,440,625 | Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers | Jun 26, 07 | May 14, 13 | THE UNIVERSITY OF BRITISH COLUMBIA |
| 8,440,626 | Antineoplastic peptides | Aug 26, 10 | May 14, 13 | ABBOTT GMBH & CO. KG |
| 8,440,630 | Akt activity specifically inhibiting polypeptide | Dec 14, 04 | May 14, 13 | JAPAN SCIENCE AND TECHNOLOGY AGENCY |
| 8,440,644 | Compounds as receptor modulators with therapeutic utility | May 20, 11 | May 14, 13 | ALLERGAN, INC. |
| 8,440,661 | Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines | May 13, 10 | May 14, 13 | SIGNAL PHARMACEUTICALS, LLC |
| 8,440,670 | Pyridopyrazindione derivative and its use as an antiulcer drug | Sep 03, 12 | May 14, 13 | INNOVATIVE PHARMACOLOGY RESEARCH OOO (IPHAR) |
| 8,440,682 | 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors | Jun 07, 12 | May 14, 13 | NOVARTIS AG |
| 8,440,689 | Fused heteroaromatic pyrrolidinones | Dec 17, 10 | May 14, 13 | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 8,440,694 | receptor | Sep 13, 12 | May 14, 13 | ABBOTT GMBH & CO. KG |
| 8,440,788 | N-terminal VDAC variants and uses thereof | Apr 10, 07 | May 14, 13 | BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY LTD. |
| 8,440,795 | Kunitz-type recombinant inhibitor | Mar 14, 07 | May 14, 13 | COINFAIR-CONSÓRCIO DE INDÚSTRIAS FARMACÊUTICAS |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2013/0121,934 | Self Emulsified Compositions | Nov 11, 11 | May 16, 13 | AVON PRODUCTS INC. |
| 2013/0121,996 | Novel Complex Mutations in the Epidermal Growth Factor Receptor Kinase Domain | Oct 30, 12 | May 16, 13 | ROCHE MOLECULAR SYSTEMS INC. |
| 2013/0122,039 | V. Cholera hypereexpressing recombinant cholera toxin B subunit showing dual immunogenicity | Oct 16, 12 | May 16, 13 | Not available |
| 2013/0122,051 | Methods of preparing progesterone pharmaceutical compositions | May 25, 12 | May 16, 13 | PHARMACEUTICS INTERNATIONAL, INC. |
| 2013/0122,076 | Transdermal Patch Having Ultrasound Transducer for Administering Thrombolytic Reagents to Patients Having a Protein Misfolding Disease | Mar 27, 12 | May 16, 13 | Not available |
| 2013/0122,080 | PHARMACEUTICAL COMPOSITION CAPABLE OF IMMUNO-REGULATION OR ENHANCEMENT OF IMMUNE RESPONSE | Mar 05, 12 | May 16, 13 | Not available |
| 2013/0122,098 | Method and composition to improve absorption of therapeutic agents | Nov 14, 11 | May 16, 13 | BAYER HEALTHCARE LLC |
| 2013/0122,105 | Methods and Compositions for Gene Therapy and GHRH Therapy | Nov 16, 11 | May 16, 13 | Not available |
| 2013/0122,110 | ANTI-HUMAN UROTHELIAL CARCINOMA OF SUPERCRITICAL CARBON DIOXIDE EXTRACT OF CINNAMOMUM SUBAVENIUM, AND THE PREPARATION PROCESS AND USES | Mar 21, 12 | May 16, 13 | KAOHSIUNG MEDICAL UNIVERSITY |
| 2013/0122,115 | Rebound hoof pack | Nov 16, 11 | May 16, 13 | Not available |
| 2013/0122,116 | PAIN RELIEVER COMPOSITION | Nov 11, 11 | May 16, 13 | Not available |
| 2013/0123,238 | Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to treat addictive and alcohol-related disorders | Jul 13, 12 | May 16, 13 | Not available |
| 2013/0123,255 | COMBINATION OF A PI3K INHIBITOR AND A MEK INHIBITOR | Nov 06, 12 | May 16, 13 | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 2013/0123,319 | Medthod of Treating a systemic inflammatory disorder and damaged internal tissues | Nov 15, 11 | May 16, 13 | Not available |
| 2013/0123,320 | TOPICAL COMPOSITION FOR PAIN RELIEF | Nov 14, 11 | May 16, 13 | Not available |
| 2013/0123,433 | METHOD FOR PREPARING POLY(ALLYLAMINE) HYDROCHLORIDE AND DERIVATIVES THEREFROM | Nov 14, 11 | May 16, 13 | FORMOSA LABORATORIES INC. |
| 2013/0123,741 | FLEXIBLE STERILE BAG CONTAINING PHARMACEUTICAL PRODUCTS AND DILUANT SEPARATELY AND METHOD OF MAKING THE SAME | Sep 28, 12 | May 16, 13 | GALENOVA INC |
| 2013/0123,742 | Method of a Pharmaceutical Delivery System for Use Within a Joint Replacement | Mar 01, 12 | May 16, 13 | Not available |
| 2013/0115,194 | HEPATITIS C VIRUS INHIBITORS | Nov 02, 12 | May 09, 13 | Not available |
| 2013/0115,201 | Fluid Supplement with Prenatal Vitamins | Nov 03, 11 | May 09, 13 | Not available |